Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era
about
Elimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition ModelBurden of disease from cryptosporidiosis.Getting to 90-90-90 in paediatric HIV: What is needed?Hippocampal Neuronal Loss in Infant Macaques Orally Infected with Virulent Simian Immunodeficiency Virus (SIV).Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database.Beyond early infant diagnosis: case finding strategies for identification of HIV-infected infants and children.Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatmentGuidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theShort communication: kidney dysfunction among HIV-infected children in Latin America and the CaribbeanUsing health provider insights to inform pediatric HIV disclosure: a qualitative study and practice framework from Kenya.Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric populationPost-HAART outcomes in pediatric populations: comparison of resource-limited and developed countriesRate of candidiasis among HIV-infected children in Spain in the era of highly active antiretroviral therapy (1997-2008).Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Survival of HIV-infected children: a cohort study from the Asia-Pacific region.Improved identification and enrolment into care of HIV-exposed and -infected infants and children following a community health worker intervention in Lilongwe, MalawiRisk of triple-class virological failure in children with HIV: a retrospective cohort studyPsychosocial implications of HIV serostatus disclosure to youth with perinatally acquired HIVMedication adherence in children and adolescents with HIV infection: associations with behavioral impairment.Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study.Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States.Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescentsAntiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes.Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment.Cost-effectiveness of early infant HIV diagnosis of HIV-exposed infants and immediate antiretroviral therapy in HIV-infected children under 24 months in ThailandOpportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983-2007.Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programsLong-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020ANephrotoxicity of HAARTTime trends of baseline demographics and clinical characteristics of HIV infected children enrolled in care and treatment service in Dar es Salaam, Tanzania.Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescentsMortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004)Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz.Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions.The effect of aging, nutrition, and exercise during HIV infection.Is it safe? Talking to teens with HIV/AIDS about death and dying: a 3-month evaluation of Family Centered Advance Care (FACE) planning - anxiety, depression, quality of life.Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infectionPRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years.Treatment initiation factors and cognitive outcome in youth with perinatally acquired HIV infection
P2860
Q26778483-3B236051-0FF6-4816-9FB8-BB5A10AAB576Q30384769-538C99B0-C709-45C4-97B0-852F00724F8AQ30385352-424FDB56-8496-4805-A2B5-DB344BF9CC32Q33607923-70C458CB-A46D-4128-9973-655C1A1616EDQ33748141-A04AFD44-6482-476F-A157-DA76DF82B77AQ34006876-847E283D-5227-4A46-B1DC-8ABD29E1DECFQ34083742-E32BAAB6-E10A-4849-85BB-2A74E1AA83B5Q34212799-82E1190D-C383-48BB-8B81-0B25D8EB3DD4Q34267297-FB49C902-9422-46F2-8DB7-1E3F1349CD69Q34283983-F094622B-C494-404B-B5F5-5D343CE5CAB5Q34367468-5375F1DF-2300-45D4-9472-8323EBC03911Q34513045-0FFAFFDF-F2AD-4622-8E9D-5245D2A5CCEAQ34627658-1F8E3F3E-81EF-4104-A5DC-FB8ED1A2FFB9Q34683397-A2A1B7FF-CC92-4952-BC3D-82A9E3813123Q34736194-08FB7A9C-9F49-4285-A4DB-D72076E6BE93Q34773604-B1F089DE-D74B-4A10-8238-3B14A22F423EQ34876650-92DDCF0D-9182-47DE-895C-28AEADCDBE72Q34997180-98AE85F0-532A-41C2-B1CA-C4F6FE4A751FQ35006746-901DCB87-3DDE-41BB-97B4-1DB552791118Q35006958-197CF280-9075-49F8-8FE6-C1A7B8920F4BQ35019846-8D036188-3E97-4BF2-9D41-C1B1A5FD4874Q35033474-9D68D67B-5021-45DB-AA25-55197B61C790Q35072975-3ABC8DDA-7850-4532-BC81-EC720600D180Q35074791-F8548502-0895-4DE3-9833-B858A278AC3BQ35074998-2752A2B5-48E9-4F26-B945-6052E2F10461Q35121725-10A01791-2165-44AF-86D5-1A838FD1DBE0Q35147409-BBBABB4B-2F59-4406-8C1C-FAF34183521AQ35148237-8DDAB257-F4EC-476C-A145-FEB0AFA93F69Q35163596-D01E67BD-D29F-4136-B2C9-8C3B5CC01A17Q35167944-52A627EE-8C76-4769-B82B-C5293B978866Q35233180-5DAE59AF-0E17-4599-A6A9-EBAED48DFEE3Q35338750-619B7087-2F22-4948-B069-DEA9A29ACEF6Q35452217-2F097AC3-79E2-422E-8677-96507273B51DQ35547048-2EF3155B-28BB-4DAD-8A57-BD03D94BC1DAQ35557247-F62044AE-92CD-4A73-AB12-6F27205F1BCBQ35557264-3FEB6C4E-727D-4C23-A60F-0E1B7E89BA7BQ35557295-95D11811-0BA9-4C32-A2F5-B922AD4CA0CCQ35655827-FB9A31D6-7985-4FC3-94B6-EB9AF3C7FA19Q35722000-9C75E80E-13B6-4AAA-87B9-BD0402A4657DQ35772799-21990F7D-F9D3-4B94-BB52-6E191D3A8CC8
P2860
Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Declines in mortality rates an ...... children during the HAART era
@ast
Declines in mortality rates an ...... children during the HAART era
@en
Declines in mortality rates an ...... children during the HAART era.
@nl
type
label
Declines in mortality rates an ...... children during the HAART era
@ast
Declines in mortality rates an ...... children during the HAART era
@en
Declines in mortality rates an ...... children during the HAART era.
@nl
prefLabel
Declines in mortality rates an ...... children during the HAART era
@ast
Declines in mortality rates an ...... children during the HAART era
@en
Declines in mortality rates an ...... children during the HAART era.
@nl
P2093
P2860
P1476
Declines in mortality rates an ...... children during the HAART era
@en
P2093
Carol Elgie
James M Oleske
Michael T Brady
Paige L Williams
Pediatric AIDS Clinical Trials Group219/219C Team
Russell B Van Dyke
Wayne M Dankner
P2860
P356
10.1097/QAI.0B013E3181B9869F
P407
P577
2010-01-01T00:00:00Z